Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

A specific gene variation is linked to a higher risk of polycystic ovary syndrome in Caucasian women.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

A woman developed a severe skin reaction after getting a birth control implant.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Placenta products might help with hair loss, but more research is needed.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.